Synapse - Surgery

Results (35)

Recurrent Gleason score 6 prostate cancer after radiotherapy or ablation: Should we observe them all? Results from a large multicenter salvage radical prostatectomy consortium

Journal Article

Marra, G.; Calleris, G.; Conte, F.; Benfant, N.; Rajwa, P.; Ahmed, M.; Abreu, A.; Cacciamani, G.; Smith, J. A.; Joniau, S.; more...
European Urology Focus (2024)

Fulltext@MSK | Save

The highest grade group does not drive the risk of recurrence when systematic and multiparametric magnetic resonance imaging (MRI)-targeted biopsies are discordant: Preliminary findings using radical prostatectomy pathology as a surrogate for MRI-targeted biopsy grade

Journal Article

Scuderi, S.; Pellegrino, F.; Tin, A.; Beech, B. B.; Gandaglia, G.; Stabile, A.; Eastham, J. A.; Montorsi, F.; Briganti, A.; Vickers, A. J.
European Urology Focus (2024)

Fulltext@MSK | Save

Retroperitoneal lymph node dissection in patients with stage II seminomatous germ cell tumour

Journal Article

Oing, C.; Rescigno, P.; Paffenholz, P.; Heinzelbecker, J.; Patrikidou, A.; Matulewicz, R. S.; Huddart, R.
European Urology Focus (2024)

Fulltext@MSK | Save

Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy

Journal Article

Hahn, A. W.; Kotecha, R. R.; Viscuse, P. V.; Pieretti, A. C.; Wiele, A. J.; Jonasch, E.; Lee, C. H.; Gao, J.; Zurita, A. J.; Shah, A. Y.; more...
European Urology Focus (2023)

Fulltext@MSK | Save

Outcomes of grade group 2 and 3 prostate cancer on initial versus confirmatory biopsy: Implications for active surveillance

Journal Article

Perera, M.; Jibara, G.; Tin, A. L.; Haywood, S.; Sjoberg, D. D.; Benfante, N. E.; Carlsson, S. V.; Eastham, J. A.; Laudone, V.; Touijer, K. A.; more...
European Urology Focus (2023)

Fulltext@MSK | Save

Salvage radical prostatectomy for recurrent prostate cancer following first-line nonsurgical treatment: Validation of the European Association of Urology criteria in a large, multicenter, contemporary cohort

Journal Article

Calleris, G.; Marra, G.; Benfant, N.; Rajwa, P.; Ahmed, M.; Abreu, A.; Cacciamani, G.; Ghoreifi, A.; Ribeiro, L.; Westhofen, T.; more...
European Urology Focus (2023)

Fulltext@MSK | Save

Bladder cancer carcinogens: Opportunities for risk reduction

Review

Gaffney, C. D.; Katims, A.; D'Souza, N.; Bjurlin, M. A.; Matulewicz, R. S.
European Urology Focus (2023)

Fulltext@MSK | Save

Thermal partial prostate ablation for intermediate- and high-risk prostate cancer: Con

Editorial

Gaffney, C. D.; Ehdaie, B.
European Urology Focus (2023)

Fulltext@MSK | Save

Background and update for ECOG-ACRIN EA8212: A randomized phase 3 trial of intravesical bacillus Calmette-Guérin (BCG) versus intravesical docetaxel and gemcitabine treatment in BCG-naïve high-grade non–muscle-invasive bladder cancer (BRIDGE)

Review

Kates, M.; Chu, X.; Hahn, N.; Pietzak, E.; Smith, A.; Shevrin, D. H.; Crispen, P.; Williams, S. B.; Daneshmand, S.; Packiam, V. T.; more...
European Urology Focus (2023)

Fulltext@MSK | Save

Prostate-specific antigen density cutoff of 0.15 ng/ml/cc to propose prostate biopsies to patients with negative magnetic resonance imaging: Efficient threshold or legacy of the past?

Journal Article

Pellegrino, F.; Tin, A. L.; Martini, A.; Vertosick, E. A.; Porwal, S. P.; Stabile, A.; Gandaglia, G.; Eastham, J. A.; Briganti, A.; Montorsi, F.; more...
European Urology Focus (2023)

Fulltext@MSK | Save